Correction of glycogen storage disease type III with rapamycin in a canine model

Characterization of a canine model of glycogen storage disease type IIIa

(2012) H. Yi et al.   Disease Models & Mechanisms

Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III

(2012) Baodong Sun et al.   MOLECULAR GENETICS AND METABOLISM

Mechanisms of hepatic fibrogenesis

(2011) Ursula E. Lee et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

mTOR signaling in disease

(2011) Eva Dazert et al.   CURRENT OPINION IN CELL BIOLOGY

Regulation of Autophagy by Kinases

(2011) Savitha Sridharan et al.   Cancers

Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis

(2010) Eleonora Patsenker et al.   JOURNAL OF HEPATOLOGY

Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress

(2010) Shomit Sengupta et al.   MOLECULAR CELL

Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe disease

(2010) Karen M. Ashe et al.   MOLECULAR GENETICS AND METABOLISM

mTOR: dissecting regulation and mechanism of action to understand human disease: Figure 1

(2009) Deborah C.I. Goberdhan et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

mTOR and the control of whole body metabolism

(2009) Pazit Polak et al.   CURRENT OPINION IN CELL BIOLOGY

Long-term effects of rapamycin treatment on insulin mediated phosphorylation of Akt/PKB and glycogen synthase activity

(2008) Shailly Varma et al.   EXPERIMENTAL CELL RESEARCH

Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II

(2008) Gaelle Douillard-Guilloux et al.   HUMAN MOLECULAR GENETICS